By proceeding, you agree to our Terms of Use and Privacy Policy.
MAP is the leading global meeting dedicated to precision oncology, defined as molecular profiling of tumours to identify targetable alterations. This oncology field is fast evolving and has now entered the mainstream of clinical practice.
Learn how to use genomic data for treating cancer patients, matching such data to a specific drug or therapy.
Explore lymphoma from pathology sections, multispectral and photon-counting x-ray imaging and utilising ai for smart workflows in radiography.
Discover the role of virtual diagnostics in improving patient treatment journeys and ai-based prediction of risk of breast cancer.
Engage and network with experts like Sir Michael Brady, Ricky Harminder Bhogal, Penny Kechagioglou, Sue Astley and Hazel Edwards.
ESMO stands by the side of those engaged in action against cancer on a global level: driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to caring for the carers who lead the effort in their communiti
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases.
At Janssen, we never stop working toward a future where disease is a thing of the past.
For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.